Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.730
-0.110 (-5.98%)
At close: Jul 2, 2026, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Jul 2, 2026, 6:42 PM EDT
Nautilus Biotechnology Employees
Nautilus Biotechnology had 127 employees as of March 31, 2026. The number of employees decreased by 3 or -2.31% since the number was last reported on December 31, 2025.
Employees
127
Change
-3
Growth
-2.31%
Revenue / Employee
n/a
Profits / Employee
-$449,488
Market Cap
219.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 127 | -3 | -2.31% |
| Dec 31, 2025 | 130 | -25 | -16.13% |
| Dec 31, 2024 | 155 | -12 | -7.19% |
| Dec 31, 2023 | 167 | 33 | 24.63% |
| Dec 31, 2022 | 134 | 21 | 18.58% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Codexis | 146 |
| Coherus Oncology | 145 |
| Keros Therapeutics | 87 |
| Compugen | 75 |
| Armata Pharmaceuticals | 61 |
| Protara Therapeutics | 46 |
| Whitehawk Therapeutics | 29 |
NAUT News
- 18 days ago - Nautilus Biotechnology Transcript: AGM 2026 - Transcripts
- 2 months ago - Nautilus Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Nautilus Biotechnology Earnings release: Q1 2026 - Filings
- 2 months ago - Nautilus Biotechnology Quarterly report: Q1 2026 - Filings
- 2 months ago - Nautilus Biotechnology Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - Nautilus Biotechnology Proxy statement: Proxy filing - Filings
- 2 months ago - Nautilus Biotechnology Proxy statement: Proxy filing - Filings
- 3 months ago - Nautilus Biotechnology Transcript: Investor Summit Virtual Conference - Transcripts